FTC sues main pharmacy benefit administrators around insulin selling prices The company brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record cost of existence-preserving insulin medicine. This approach aligns with People initiatives, the ONC stated. The sector is tackling https://dave-s-hot-chicken-nutrit94838.blognody.com/30913790/the-ultimate-guide-to-healthcare-news